The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in…

Areata AlopeciaAlopeciaHypotrichosis+3 more

~Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT05723198

Phase 2

Efficacy of Dapagliflozin in the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

AMD is a leading cause of blindness in individuals over 50 years old, with dry AMD being the most common form. Geographic atrophy (GA) is an advanced stage of …

Retinal DegenerationRetinal DiseasesEye Diseases+2 more

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT07174687

Observational

North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

This registry study aims to confirm that FETO increases neonatal survival to discharge and reduces long-term morbidity in fetuses with isolated left CDH and o/…

Congenital Diaphragmatic HerniaCongenital AbnormalitiesNeonatal Diseases and Abnormalities+5 more

~Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT07166172